SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
SkinHealth Systems is expanding the SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device, into the UK, Ireland, Germany, France, Spain and Portugal.
The company will sell through its direct European commercial organization and leverage the established Hydrafacial provider network, with distributor-market availability expected beginning in 2027.
CEO Pedro Malha framed the move as a step toward building a broader medical aesthetics ecosystem around the Hydrafacial device footprint. No financial figures or revenue expectations were disclosed.